The HemOnc Pulse Live at ASH: Srdan Verstovsek, MD, on MPN Treatment Combinations, Timing

The HemOnc Pulse Live at ASH: Thomas Martin, MD, on Frontline Advances, Novel Agents in MyelomaПодробнее

The HemOnc Pulse Live at ASH: Naval Daver, MD, on Treating AML in Older Adults, Novel TherapiesПодробнее

The HemOnc Pulse Live at ASH: Robert Orlowski, MD, PhD, on Bispecifics, MRD in MyelomaПодробнее

The HemOnc Pulse Live at ASH: Phillip Scheinberg, MD, on CHIP, MDS Classification UpdatesПодробнее

Srdan Verstovsek, MD, on the Phase III VERIFY TrialПодробнее

"The HemOnc Pulse" Live: Ruben Mesa, MD, Discusses MPN Panel #HOPLive24Подробнее

The HemOnc Pulse Live at ASH: John DiPersio, MD, PhD, on Challenges, Role of HSCT in AMLПодробнее

The HemOnc Pulse Live at ASH: Jeffrey Lancet, MDПодробнее

Introducing The HemOnc Pulse hosted by Chadi Nabhan, MD, MBA, FACPПодробнее

Live In Chicago, It's "The HemOnc Pulse"! #HOPLive24Подробнее

Precision medicine, genomics and immunotherapies at ASH 2017Подробнее

'The HemOnc Pulse' Live: Summarizing the Unmet Needs in CLLПодробнее

Risk factors for progression in MPNsПодробнее

"The HemOnc Pulse" Live: Dr. Nowakowski Reflects on the Hodgkin Lymphoma PanelПодробнее

Highlights from ASH: Conversations with Christopher Heery and Srdan VerstovsekПодробнее

Updates in MPNs at ASH 2020Подробнее

Best of ASHПодробнее